BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15938614)

  • 1. Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding.
    Golovko MY; Faergeman NJ; Cole NB; Castagnet PI; Nussbaum RL; Murphy EJ
    Biochemistry; 2005 Jun; 44(23):8251-9. PubMed ID: 15938614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid incorporation is decreased in astrocytes cultured from alpha-synuclein gene-ablated mice.
    Castagnet PI; Golovko MY; Barceló-Coblijn GC; Nussbaum RL; Murphy EJ
    J Neurochem; 2005 Aug; 94(3):839-49. PubMed ID: 16033426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice.
    Murphy EJ; Owada Y; Kitanaka N; Kondo H; Glatz JF
    Biochemistry; 2005 Apr; 44(16):6350-60. PubMed ID: 15835924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
    Choi W; Zibaee S; Jakes R; Serpell LC; Davletov B; Crowther RA; Goedert M
    FEBS Lett; 2004 Oct; 576(3):363-8. PubMed ID: 15498564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.
    Stefanis L; Wang Q; Oo T; Lang-Rollin I; Burke RE; Dauer WT
    Eur J Neurosci; 2004 Oct; 20(7):1969-72. PubMed ID: 15380020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice.
    Barceló-Coblijn G; Golovko MY; Weinhofer I; Berger J; Murphy EJ
    J Neurochem; 2007 Apr; 101(1):132-41. PubMed ID: 17250686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localization of alpha-synuclein and its interaction with histones.
    Goers J; Manning-Bog AB; McCormack AL; Millett IS; Doniach S; Di Monte DA; Uversky VN; Fink AL
    Biochemistry; 2003 Jul; 42(28):8465-71. PubMed ID: 12859192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of alpha-synuclein in neurodegenerative diseases.
    Bennett MC
    Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl-coenzyme A binding protein expression alters liver fatty acyl-coenzyme A metabolism.
    Huang H; Atshaves BP; Frolov A; Kier AB; Schroeder F
    Biochemistry; 2005 Aug; 44(30):10282-97. PubMed ID: 16042405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analyses of alpha-synuclein expression levels in rat brain tissues and transfected cells.
    Wersinger C; Banta M; Sidhu A
    Neurosci Lett; 2004 Mar; 358(2):95-8. PubMed ID: 15026157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism.
    Golovko MY; Rosenberger TA; Faergeman NJ; Feddersen S; Cole NB; Pribill I; Berger J; Nussbaum RL; Murphy EJ
    Biochemistry; 2006 Jun; 45(22):6956-66. PubMed ID: 16734431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain.
    Totterdell S; Hanger D; Meredith GE
    Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence studies suggest a role for alpha-synuclein in the phosphatidylinositol lipid signaling pathway.
    Narayanan V; Guo Y; Scarlata S
    Biochemistry; 2005 Jan; 44(2):462-70. PubMed ID: 15641770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.
    Chandra S; Gallardo G; Fernández-Chacón R; Schlüter OM; Südhof TC
    Cell; 2005 Nov; 123(3):383-96. PubMed ID: 16269331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
    Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
    Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
    Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N
    Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein deficiency affects brain Foxp1 expression and ultrasonic vocalization.
    Kurz A; Wöhr M; Walter M; Bonin M; Auburger G; Gispert S; Schwarting RK
    Neuroscience; 2010 Mar; 166(3):785-95. PubMed ID: 20056137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage.
    Orth M; Tabrizi SJ; Tomlinson C; Messmer K; Korlipara LV; Schapira AH; Cooper JM
    Neurochem Int; 2004 Oct; 45(5):669-76. PubMed ID: 15234109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of alpha-synuclein in different brain parts of adult and aged rats.
    Adamczyk A; Solecka J; Strosznajder JB
    J Physiol Pharmacol; 2005 Mar; 56(1):29-37. PubMed ID: 15795473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids.
    Golovko MY; Rosenberger TA; Feddersen S; Faergeman NJ; Murphy EJ
    J Neurochem; 2007 Apr; 101(1):201-11. PubMed ID: 17250657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.